On the other hand, cumulating evidence indicates that MAPK signaling activation is associated with VEGF-mediated tumor progression in bladder cancer (49), which was also observed in epidermal cancer stem cells but in a NRP1-dependent manner to enhance angiogenic potential, invasion and migration (50). This evidence concerns the gene NRP1 and urinary bladder carcinoma.